Trials / Completed
CompletedNCT02043925
QT-prolongation in Psychiatric Hospitals
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 152 (actual)
- Sponsor
- KU Leuven · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Observational study in 6 psychiatric hospitals in Flanders. Patients are included when a QT-prolonging drug is added to a medication profile that already contains a potential QT-prolonging drug. An ECG is taken before the administration of the new drug and a week after starting the new drug to investigate the change in duration of the QTc-interval. Risk factors for developing QT-prolongation and blood concentrations of potassium and creatinine are documented.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | drugs linked with QT-prolongation | all the drugs that are mentioned in the lists of QT-prolonging drugs of CredibleMeds (www.crediblemeds.org) |
Timeline
- Start date
- 2010-10-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2014-01-23
- Last updated
- 2015-07-28
Locations
1 site across 1 country: Belgium
Source: ClinicalTrials.gov record NCT02043925. Inclusion in this directory is not an endorsement.